Health IT

Reimbursement, readmissions, reducing provider costs among priorities for Blueprint Health entrepreneurs

Helping pharmacy benefit managers allocate money to medication adherence programs, providing three dimensional surgical animations on mobile devices for salespeople and simplifying workers’ compensation bills are among the problems being attacked by the nine companies in Blueprint Health’s second class that kicked off this week. The New York program led by Mathew Farkash and Dr […]

Helping pharmacy benefit managers allocate money to medication adherence programs, providing three dimensional surgical animations on mobile devices for salespeople and simplifying workers’ compensation bills are among the problems being attacked by the nine companies in Blueprint Health’s second class that kicked off this week.

The New York program led by Mathew Farkash and Dr Brad Weinberg, which is part of the Global Accelerators Network, works with more than 150 mentors cultivated from referrals from TechStars that span providers, serial entrepreneurs, venture capital firms, health IT companies, pharmaceutical companies and payers, most recently Humana, which also became a sponsor for the program. Blueprint benefited from TechStars’ network, which has helped cultivate the referrals that helped it build up the mentor program.

Here’s a list of Blueprint Health’s second class of startups provided by the accelerator.

AdhereTech provides a patented, connected pill or liquid bottle that can accurately measure if a medication is dispensed. The company seeks to help clinical research organizations to reduce the cost of clinical study assessment.

Allazo Health helps pharmacy benefit managers allocate money to medication adherence programs providing a data analytics program to determine the combination of intervention techniques that will provide the greatest outcomes.

Daisy Bill seeks to tackle the issue of physicians getting reimbursed for services provided through workers compensation insurer through a software as a service platform to submit worker’s compensation claims electronically.

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

EMBI or Emergency Medicine Business Intelligence helps hospitals identify areas where they can increase revenue and reduce costs, specifically down to a department and patient level.

Enhatch has developed a mobile-based program for pharmaceutical and medical device companies’ sales forces to present three-dimensional surgical animations to physicians and surgeons.

GeriJoy Technologies is offering a service to assisted living facilities and nursing homes to monitor residents using video surveillance and interaction with family members and a virtual caregiver through tablet computer-enabled software.

Health Recovery Solutions seeks to help hospitals reduce congestive heart failure re-admissions in response to on portion of the Affordable Care Act which will reduce Medicare reimbursements for hospitals with a higher than national average readmission rates for heart failure as well as heart attack and pneumonia. It offers a care management service that scores patients daily on their re-admission risk.

Medikly is intended to help pharmaceutical companies develop social media and advertising platforms for medical education and marketing campaigns.

Symbiosis Health helps employers increase enrollment and retention in their high-deductible health plan in a program it claims will help employees save money.

The program runs to the beginning of October, culminating in a demo day October 4. Startups get $20,000 and access to the accelerator’s Soho offices. In exchange, Blueprint Health gets a 6 percent equity stake in each of the companies.

It also accepted three floating founders who can offer their insights to participating startups, participate in all activities in the accelerator with the same access to the mentor community that the teams have. They also receive a monthly stipend for participating as a floating founder.

Although Blueprint Health was the first accelerator in New York dedicated to healthcare oriented companies, it has since been joined by other programs such as WellTech, New York Digital Health Accelerator and StartupHealth, underlining the city’s growth as a healthcare start-up hub.

Earlier this year Blueprint founders said they would seek to house 100 startups that can choose between memberships from $250 to $400 with privileges that include discounted access to Blueprint Health classes and conference room access.